VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is the first to demonstrate the isolation and analysis of >99% pure circulating tumor-derived DNA (ctDNA).
VolitionRx (VNRX) stock jumped 70% in pre-market after achieving 99% pure tumor DNA isolation and detecting 49/49 cancers in a blind study.
Targets $36 Billion TAM in Early Cancer Detection and MRD. Company in active discussions with global diagnostic leaders to accelerate commercialization. HENDERSON, Nev., March 18, ...
A research team from the Guangzhou Institutes of Biomedicine and Health under the Chinese Academy of Sciences, Guangzhou Medical University and other institutions, utilized membrane vesicles from red ...
According to the study published on Wednesday in the journal Cell, the therapy proposes a brand-new strategy in the field of regenerative medicine, shedding fresh light on intervention in refractory ...
Invincible Season 4 returns with an explosive three-part premiere, as Mark Grayson faces intense battles and family tensions.
A man convicted in a murder case, holding that Call Detail Records (CDRs) could not be relied upon in evidence unless accompanied by the mandatory certificate under Section 65-B of the Indian Evidence ...
A new X-ray imaging technique could transform how hospitals analyze tissue samples, potentially speeding up diagnoses and ...
RIKEN researchers have demonstrated a method that can detect tiny amounts of biomarkers in liquid samples and can distinguish between highly similar biomarkers. This promises to boost the versatility ...
The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells ...
Explore the outcomes of CSW70 and the progress made against gender equality amid rising pushbacks on women's rights.
Memo Genesis is launching in the United States and Canada as a dietary supplement formulated to support cognitive health, combat the memory parasite (cadmium chloride), and restore neural pathways ...